• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROGENIKA BIOPHARMA, S.A ID CORE XT; ANTIGEN GENOTYPING TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROGENIKA BIOPHARMA, S.A ID CORE XT; ANTIGEN GENOTYPING TEST Back to Search Results
Catalog Number 1020220034
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/29/2023
Event Type  malfunction  
Manufacturer Narrative
The genomic dna sample was sent to grifols laboratory solutions for dna sequencing.Next generation sequencing interrogated rh genes proximal promoter, exons 1-10, and portions of intron 2-3.A hybrid rhce allele containing rhd exons 2 and 3 was found in rhce gene, and sequencing provided the genotype rhce*ce (rhce*01), rhce*ce-d(2-3)-ce.However, id core xt reported the genotype as rhce*ce.Id core xt determines the presence of c antigen by interrogating the polymorphism c.335+3039ins109 in rhce gene intron 2.The extent of the rhd exon 2-intron 2-exon 3 sequence includes the replacement of rhce*c intron 2 sequence and explains the failure of id core xt to predict a c+ phenotype.Id core xt predicted a c- phenotype, but the serological data indicated a c+ phenotype, attributable to the presence of the rare rhce*ce-d(2-3)-ce allele.This id core xt false negative result is considered a discrepant result and then a malfunction.Nevertheless, further serological investigation is recommended to fully characterize this unreported hybrid allele.This limitation is covered by the assay limitations described in the id core xt package insert limitations 1 and 9.
 
Event Description
It was reported that the sample (b)(6), from "(b)(6)", was tested with serology.The test result was positive (c+), which contrasted with the molecular typing performed on (b)(4) 2023, using the id core xt assay which provided negative results (c-) with id core xt analysis software v3.0.2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID CORE XT
Type of Device
ANTIGEN GENOTYPING TEST
Manufacturer (Section D)
PROGENIKA BIOPHARMA, S.A
ibaizabal bidea, edificio 504
parque tecnologico de bizkaia
derio, bizkaia 48160
SP  48160
Manufacturer Contact
jokin amo
ibaizabal bidea, edificio 504
parque tecnologico de bizkaia
derio, bizkaia 48160
SP   48160
MDR Report Key18812843
MDR Text Key337633028
Report Number3006413195-2024-00007
Device Sequence Number1
Product Code PEP
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/29/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1020220034
Device Lot Number0203000031
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/31/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/27/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-